An Unbiased Evaluation of CK2 Inhibitors by Chemoproteomics
Authors:
- Laszlo GyenisLGLaszlo Gyenis
- John LenehanJLJohn Lenehan
- Maria BretnerMBMaria Bretner
- Lee M. GravesLGLee M. Graves
- Timothy A. HaysteadTHTimothy A. Haystead
- David W. LitchfieldDLDavid W. Litchfield
Open Access
- 1 June 2008
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 7 (6) , 1077-1088
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interactionBiochemical Journal, 2007
- Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsNature Biotechnology, 2007
- Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954Biochemical and Biophysical Research Communications, 2005
- Validation of protein kinase CK2 as oncological targetApoptosis, 2005
- Protein kinase CK2 phosphorylates and upregulates Akt/PKBCell Death & Differentiation, 2005
- CK2 Phosphorylation of the Armadillo Repeat Region of β-Catenin Potentiates Wnt SignalingJournal of Biological Chemistry, 2003
- Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1Biochemical Journal, 2001
- The Development-associated Cleavage of Lens Connexin 45.6 by Caspase-3-like Protease Is Regulated by Casein Kinase II-mediated PhosphorylationJournal of Biological Chemistry, 2001
- Protein kinase CK2 in mammary gland tumorigenesisOncogene, 2001
- The Regulatory β Subunit of Protein Kinase CK2 Mediates Formation of Tetrameric CK2 ComplexesJournal of Biological Chemistry, 2000